Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Circulation

• Publication date

  1992-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.85.6.2025PMID 1534286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

  2009cited by this paper
• Genetic basis of lipoprotein disorders.

  1995cited by this paper
• Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

  1992cited by this paper
• Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.

  1991cited by this paper
• Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease.

  1991cited by this paper
• Causes of High Blood Cholesterol

  1990cited by this paper
• DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease.

  1990cited by this paper
• Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11.

  1989cited by this paper
• Association between a specific apo B mutation and familial defective apoB100

  1989cited by this paper
• Human genetics and coronary heart disease: a public health perspective.

  1989cited by this paper
• Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.

  1989cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Molecular basis of familial hypercholesterolemia.

  1989cited by this paper
• Genetic factors affecting blood lipoproteins: the candidate gene approach.

  1988cited by this paper
• Very Low Density Lipoprotein Triglyceride Metabolism in Relatives of Hypertriglyceridemic Probands: Evidence for Genetic Control of Triglyceride Removal

  1988cited by this paper
• Effect of hospitalization on high-density lipoprotein cholesterol in patients undergoing elective coronary angiography.

  1988cited by this paper
• Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions.

  1987cited by this paper
• DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis.

  1987cited by this paper
• Enzyme-linked immunosorbent assay for human plasma apolipoprotein B.

  1987cited by this paper
• DNA inversion within the apolipoprotein AI-CIII-AIV gene cluster of certain patients with premature atherosclerosis

  1987cited by this paper
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

  1986cited by this paper
• A receptor-mediated pathway for cholesterol homeostasis.

  1986cited by this paper
• Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

  1986cited by this paper
• A major gene for primary hypoalphalipoproteinemia.

  1986cited by this paper
• Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

  1986cited by this paper
• Metabolism of apolipoproteins A-I, A-II, and A-IV.

  1986cited by this paper
• Apolipoproteins and coronary artery disease.

  1986cited by this paper
• Low Density Lipoprotein Metabolism in Familial Combined Hyperlipidemia: Mechanism of the Multiple Lipoprotein Phenotypic Expression

  1984cited by this paper
• Apoproteins B and A-I and coronary artery disease in humans.

  1984cited by this paper
• Primary and familial hypoalphalipoproteinemia.

  1984cited by this paper
• Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency.

  1984cited by this paper
• Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease.

  1983cited by this paper
• Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

  1982cited by this paper
• Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

  1982cited by this paper
• Doctors' wider responsibilities.

  1981cited by this paper
• Familial hypo-alpha-lipoproteinemia.

  1981cited by this paper
• Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

  1980cited by this paper
• Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

  1980cited by this paper
• Plasma-triglycerides in regulation of H.D.L.-cholesterol levels.

  1978cited by this paper
• Serum lipids in angiographically assessed coronary atherosclerosis.

  1978cited by this paper
• Family study of serum lipids and lipoproteins in coronary heart-disease.

  1973cited by this paper
• Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

  1973cited by this paper
• Serum lipoprotein patterns in patients with coronary atherosclerosis.

  1973cited by this paper
• Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

  1973cited by this paper
• Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.

  1973cited by this paper
• Hyperlipidemia in Coronary Heart Disease

  1973cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

  1967cited by this paper
• Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

  1967cited by this paper
• Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

  1967cited by this paper
• Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

  1967cited by this paper
• The Increased Risk of Death from Ischaemic Heart Disease in First Degree Relatives of 121 Men and 96 Women with Ischaemic Heart Disease

  1966cited by this paper
• Abnormal histidine metabolism in thyrotoxicosis in man. A possible index of impaired folate function.

  1965cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper
• Enzyme-linked Immunosorbent Assay for Human Plasma Apolipoprotein B

  year unknowncited by this paper

• Organic electrochemical transistors (OECT) based biosensors for the detection of small molecule metabolites.

  2026cites this paper
• Discovery of ancestry-specific variants associated with clopidogrel response among Caribbean Hispanics

  2025cites this paper
• Behavioral, Clinical, and Coronary Artery Calcium Screening for Prevention and Treatment of Subclinical Atherosclerosis: Implications for Health Education

  2024cites this paper
• High density lipoprotein infusion therapy: A review.

  2024cites this paper
• Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics

  2023cites this paper
• HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study

  2023cites this paper
• Lipoprotein(a) is associated with premature coronary artery disease: a meta-analysis

  2023cites this paper
• Association of aortic dissection and lipoprotein (a): a meta-analysis

  2023cites this paper
• Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome

  2023influential citation
• Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.

  2022influential citation
• Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome.

  2022cites this paper
• Triglycerides: How to Manage Patients with Elevated Triglycerides and When to Refer?

  2022cites this paper
• Therapeutic Potential of VEGF-B in Coronary Heart Disease and Heart Failure: Dream or Vision?

  2022cites this paper
• Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review.

  2022cites this paper
• The relationship between acute cardiac attack and LDL-C serum levels in cardiac and CCU inpatients in Hajar hospital: Replying to a paradox

  2022cites this paper
• Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?

  2022cites this paper
• Lipid Parameters and Proprotein Convertase Subtilisin/Kexin Type 9 in Healthy Lebanese Adults

  2022cites this paper
• Analysis of the APOB Gene and Apolipoprotein B Serum Levels in a Mexican Population with Acute Coronary Syndrome: Association with the Single Nucleotide Variants rs1469513, rs673548, rs676210, and rs1042034

  2022cites this paper
• APOE and KLF14 genetic variants are sex-specific for low high-density lipoprotein cholesterol identified by a genome-wide association study

  2022cites this paper
• Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a).

  2021cites this paper
• A Modern Approach to Dyslipidemia

  2021cites this paper
• The Role of the VEGF Family in Coronary Heart Disease

  2021cites this paper
• Lipoprotein (a): Recent Updates on a Unique Lipoprotein

  2021cites this paper
• Correlations between dyslipidemia and cardiovascular disease in patients of type 2 diabetes mellitus

  2021cites this paper
• Lipoproteins

  2021cites this paper
• Familial Hypercholesterolemia, Familial Combined Hyperlipidemia and Elevated Lipoprotein(a) in Patients with Premature Coronary Artery Disease.

  2021cites this paper
• Efficacy of Generic Atorvastatin in a Real-World Setting

  2021cites this paper
• The Prevalence of Dyslipidemia in the Niger Delta Region of Southern Nigeria

  2021cites this paper
• Association of the rs17574 DPP4 Polymorphism with Premature Coronary Artery Disease in Diabetic Patients: Results from the Cohort of the GEA Mexican Study

  2021cites this paper
• CPAA_A_285750 45..51

  2021cites this paper
• The association between apolipoprotein A‐1 plasma level and premature coronary artery disease: A systematic review and meta‐analysis

  2021cites this paper
• risk factors associated with cardiovascular diseases among adults attending the primary health care centers in qatar a cross sectional study

  2020cites this paper
• The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects

  2020cites this paper
• Predictive value of plasma lipid levels for coronary artery disease (CAD)

  2020cites this paper
• Hypercholesterolemia and Dyslipidemia

  2020cites this paper
• Genetic Disorders of Lipoprotein Metabolism

  2020cites this paper
• A COMPARATIVE STUDY OF LIPID PROFILE AND BODY MASS INDEX IN CORONARY HEART DISEASE PATIENTS AND HEALTHY SMOKERS SUDANESE SUBJECTS

  2020cites this paper
• The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests

  2020cites this paper
• Genetic Disorders of Lipoprotein Metabolism: Diagnosis and Management

  2020cites this paper
• Comparison of Framingham 10-Year Cardiovascular Event Risks in Native- and Foreign-born Primary Healthcare Populations in Sweden

  2020cites this paper
• Natural Killer Response and Lipo-Metabolic Profile in Adults with Low HDL-Cholesterol and Mild Hypercholesterolemia: Beneficial Effects of Artichoke Leaf Extract Supplementation

  2019influential citation
• High-density lipoprotein ameliorates palmitic acid-induced lipotoxicity and oxidative dysfunction in H9c2 cardiomyoblast cells via ROS suppression

  2019cites this paper
• Atherogenic Index In Plasma and Risk of Cardiovascular Events

  2019cites this paper
• Genetic polymorphisms of the SHBG gene can be the effect on SHBG and HDL-cholesterol levels in Coronary Heart Disease: a case–control study

  2019cites this paper
• Non-HDL-c/TC: A Novel Lipid-Related Marker in the Assessment of Severity of Coronary Artery Lesions and Cardiovascular Outcomes

  2019cites this paper
• Change of HDL in Various Diseases

  2019cites this paper
• Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency.

  2019cites this paper
• Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.

  2019cites this paper
• Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden.

  2019cites this paper
• Advanced Lipid Testing

  2019cites this paper
• Prognostic Value of Lipoprotein(a) Levels in Patients Undergoing Coronary Angiography for Premature Acute Coronary Syndromes

  2019cites this paper
• The biochemical and genetic diagnosis of lipid disorders

  2019cites this paper
• Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7

  2019influential citation
• Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors.

  2019cites this paper
• There is an association between a genetic polymorphism in the ZNF259 gene involved in lipid metabolism and coronary artery disease.

  2019cites this paper
• Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk

  2019cites this paper
• History and Population-Ascertained

  2019cites this paper
• Associations of low HDL cholesterol level and premature coronary heart disease with functionality and phospholipid composition of HDL and with plasma oxLDL antibody levels

  2019cites this paper
• Cardiovascular Effects of Cyclical Dietary Vitamin C Withdrawal in Mice Deficient in Internal Synthesis Vitamin C and producing human lipoprotein (a): Gulo(-/-); Lp(a)+

  2019cites this paper
• Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population‐Ascertained Hyperlipidemias

  2019cites this paper
• Genetic and secondary causes of severe HDL deficiency and cardiovascular disease1

  2018influential citation
• DNA methylation in human lipid metabolism and related diseases

  2018cites this paper
• The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia

  2018cites this paper
• Dyslipidemic Effect of Doxorubicin and Etoposide: A Predisposing Factor for theAntineoplastic Drugs-induced Cardiovascular Diseases

  2018cites this paper
• Coronary artery disease risk and lipidomic profiles are similar in familial and population-ascertained hyperlipidemias

  2018cites this paper
• Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials

  2018cites this paper
• Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease

  2018cites this paper
• Effect of the gluten‐free diet on cardiovascular risk factors in patients with coeliac disease: A systematic review

  2018cites this paper
• Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer advantages?

  2018cites this paper
• Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein.

  2018cites this paper
• Response of vascular mesenchymal stem/progenitor cells to hyperlipidemia

  2018cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers.

  2018cites this paper
• Dyslipidemia in Metabolic Syndrome: an Overview of Lipoprotein- Related Disorders

  2017influential citation
• Effects of Some Selected Solvent Extracts of Avocado Pear ( Persea americana ) on Cholesterol/HDL Ratio in Albino Rats

  2017cites this paper
• Control integral de los factores de riesgo vascular en el paciente anciano con alto riesgo. Eficacia de un nuevo modelo asistencial : estudio coral

  2017cites this paper
• Monogenetic disorders of the cholesterol metabolism and premature cardiovascular disease

  2017cites this paper
• Evolutionary public health: introducing the concept.

  2017cites this paper
• Comprehensive genotyping in dyslipidemia: mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants

  2017cites this paper
• A 1 Lipoprotein ( a ) , Lipid Profile and Mean Platelet Volume in Hypothyroid Patients in Sana ' a , Yemen : A Case-Control Study

  2017cites this paper
• LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis

  2017cites this paper
• Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1.

  2017cites this paper
• METABOLIC AND GENETIC ASPECTS OF FCH 803

  2017cites this paper
• Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism

  2017cites this paper
• Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.

  2017cites this paper
• Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus

  2017cites this paper
• Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors

  2017cites this paper
• Control del colesterol-LDL en pacientes con dislipidemias genéticas seguidos en unidades de lípidos y riesgo vascular de la Sociedad Espade Arteriosclerosis

  2016cites this paper
• Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies.

  2016cites this paper
• Experimental Biology for the Identification of Causal Pathways in Atherosclerosis

  2016influential citation
• Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.

  2016cites this paper
• Lipoprotein (a), Lipid Profile and Mean Platelet Volume in Hypothyroid Patients in Sana'a, Yemen: A Case-Control Study

  2016cites this paper
• Parity and serum lipid levels: a cross-sectional study in chinese female adults

  2016cites this paper
• Diagnosis and treatment of high density lipoprotein deficiency.

  2016cites this paper
• Fasting or Nonfasting Lipid Measurements: It Depends on the Question.

  2016cites this paper
• Prevalence, clinical features, and prognosis of patients with extremely low high-density lipoprotein cholesterol.

  2016cites this paper
• Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process

  2016cites this paper
• Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.

  2016cites this paper
• Study of relationship of serum Lipid Profile and etiological factors of Ischaemic Heart Diseases

  2016cites this paper
• The Contribution of GWAS Loci in Familial Dyslipidemias

  2016cites this paper
• The unresolved mystery of high-density lipoprotein: time for a paradigm shift?

  2016cites this paper